Loading
companiesCompany
Novo Holdings
The investment company of the Novo Nordisk Foundation, based near Copenhagen. It is one of the largest life science investors in the world and its venture portfolio includes cancer companies such as Myricx Bio, which Novartis agreed to buy.
Overview
Novo Holdings A/S (Tuborg Havnevej 19, 2900 Hellerup, Denmark) is 'the holding and investment company of the Novo Nordisk Foundation', controlling shareholder of Novo Nordisk and Novonesis, and 'invests in life science companies at all stages of development' alongside a broad financial portfolio. Its Life Science teams span Seed, Venture, Growth (Principal) and Planetary Health investments from Copenhagen, London, Singapore, Boston and San Francisco. The Venture Investments page describes 'one of the largest and most active life science venture investors globally', investing from 'early-stage, translatable science through commercial stage products' with board participation and an evergreen structure, and gives a venture portfolio value of DKK 17 billion across 53 companies at year-end 2025. Recent news on that page includes 'Novo Holdings portfolio company Myricx Bio agrees to be acquired by Novartis' (Myricx develops antibody-drug conjugate payloads).
Portfolio (4)
Filter the startups table| Company | Stage | Type | Cancers | Latest round |
|---|---|---|---|---|
| Adcendo Copenhagen, DK | Growth stage | biotech | Sarcomas (soft tissue, bone, GIST) | Series C 2026, $75M |
| Alentis Therapeutics Basel, CH | Growth stage | biotech | Series D 2024, $181M | |
| Callio Therapeutics Seattle, WA, US | Startup | biotech | HER2-positive breast cancer | Series A 2025, $187M |
| Obsidian Therapeutics Cambridge, MA, US | Public | cell therapy | MelanomaNon-small-cell lung cancer | Crossover 2026, $350M |
Notes
top- Founding year not stated on fetched pages and no Wikipedia article; omitted. Portfolio list is rendered client-side, so only Myricx is cited. Novo Holdings also has offices in Mumbai and Singapore.
Similar pages
- CompanyJeito Capital
Shares Alentis Therapeutics, Callio Therapeutics, Adcendo and the tag vc.
- CompanyTCGX (TCG Crossover)
Shares Obsidian Therapeutics, Adcendo and the tag vc.
- CompanyLogos Capital
Shares Obsidian Therapeutics, Adcendo and the tag vc.
- CompanyOrbiMed
Shares Alentis Therapeutics, Adcendo and the tag vc.
- CompanyRA Capital Management
Shares Alentis Therapeutics, Obsidian Therapeutics, Adcendo and the tag vc.
- CompanyFrazier Life Sciences
Shares Alentis Therapeutics, Callio Therapeutics and the tag vc.
- CompanyGilde Healthcare
Shares Adcendo and the tag vc.
- CompanyOmega Funds
Shares Callio Therapeutics and the tag vc.